• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小气道疾病、生物标志物与 COPD:我们处于什么阶段?

Small Airways Disease, Biomarkers and COPD: Where are We?

机构信息

Respiratory Research Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TT, UK.

出版信息

Int J Chron Obstruct Pulmon Dis. 2021 Feb 18;16:351-365. doi: 10.2147/COPD.S280157. eCollection 2021.

DOI:10.2147/COPD.S280157
PMID:33628018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7899307/
Abstract

The response to treatment and progression of Chronic Obstructive Pulmonary Disease (COPD) varies significantly. Small airways disease (SAD) is being increasingly recognized as a key pathological feature of COPD. Studies have brought forward pathological evidence of small airway damage preceding the development of emphysema and the detection of obstruction using traditional spirometry. In recent years, there has been a renewed interest in the early detection of SAD and this has brought along an increased demand for physiological tests able to identify and quantify SAD. Early detection of SAD allows early targeted therapy and this suggests the potential for altering the course of disease. The aim of this article is to review the evidence available on the physiological testing of small airways. The first half will focus on the role of lung function tests such as maximum mid-expiratory flow, impulse oscillometry and lung clearance index in detecting and quantifying SAD. The role of Computed Tomography (CT) as a radiological biomarker will be discussed as well as the potential of recent CT analysis software to differentiate normal aging of the lungs to pathology. The evidence behind SAD biomarkers sourced from blood as well as biomarkers sourced from sputum and broncho-alveolar lavage (BAL) will be reviewed. This paper focuses on CC-16, sRAGE, PAI-1, MMP-9 and MMP-12.

摘要

慢性阻塞性肺疾病(COPD)的治疗反应和进展差异很大。小气道疾病(SAD)越来越被认为是 COPD 的一个关键病理特征。研究提出了小气道损伤在肺气肿发展之前以及使用传统肺活量测定法检测到阻塞的病理证据。近年来,人们对 SAD 的早期检测重新产生了兴趣,这也增加了对能够识别和量化 SAD 的生理测试的需求。SAD 的早期检测可以实现早期靶向治疗,这表明有可能改变疾病进程。本文旨在回顾小气道生理学测试的现有证据。前半部分将重点介绍肺功能测试(如最大中期呼气流量、脉冲振荡和肺清除指数)在检测和量化 SAD 中的作用。还将讨论计算机断层扫描(CT)作为一种放射生物标志物的作用,以及最近的 CT 分析软件区分肺部正常老化与病理学的潜力。将回顾源自血液、源自痰和支气管肺泡灌洗(BAL)的 SAD 生物标志物的证据。本文重点介绍 CC-16、sRAGE、PAI-1、MMP-9 和 MMP-12。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448e/7899307/fccb8e26ab48/COPD-16-351-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448e/7899307/19cc639dc9c1/COPD-16-351-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448e/7899307/606e3ed9d041/COPD-16-351-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448e/7899307/fccb8e26ab48/COPD-16-351-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448e/7899307/19cc639dc9c1/COPD-16-351-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448e/7899307/606e3ed9d041/COPD-16-351-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/448e/7899307/fccb8e26ab48/COPD-16-351-g0003.jpg

相似文献

1
Small Airways Disease, Biomarkers and COPD: Where are We?小气道疾病、生物标志物与 COPD:我们处于什么阶段?
Int J Chron Obstruct Pulmon Dis. 2021 Feb 18;16:351-365. doi: 10.2147/COPD.S280157. eCollection 2021.
2
Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD.COPD 患者肺基质金属蛋白酶与小气道疾病和肺气肿定量 CT 标志物的关系。
Thorax. 2016 Feb;71(2):126-32. doi: 10.1136/thoraxjnl-2015-207428. Epub 2015 Dec 8.
3
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study.探索哮喘中小气道功能障碍的相关性和程度(ATLANTIS):一项前瞻性队列研究的基线数据。
Lancet Respir Med. 2019 May;7(5):402-416. doi: 10.1016/S2213-2600(19)30049-9. Epub 2019 Mar 12.
4
Upper airway symptoms and Small Airways Disease in Chronic Obstructive Pulmonary Disease, COPD.慢性阻塞性肺疾病(COPD)中的上气道症状与小气道疾病
Respir Med. 2022 Jan;191:106710. doi: 10.1016/j.rmed.2021.106710. Epub 2021 Dec 11.
5
Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.轻度慢性阻塞性肺疾病和肺气肿中的肺微血管血流。MESA慢性阻塞性肺疾病研究。
Am J Respir Crit Care Med. 2015 Sep 1;192(5):570-80. doi: 10.1164/rccm.201411-2120OC.
6
Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinician.慢性阻塞性肺疾病的小气道疾病:临床医生的见解和启示。
Curr Opin Pulm Med. 2020 Mar;26(2):162-168. doi: 10.1097/MCP.0000000000000637.
7
Using Novel Computed Tomography Analysis to Describe the Contribution and Distribution of Emphysema and Small Airways Disease in Chronic Obstructive Pulmonary Disease.运用新型计算机断层扫描分析技术描述肺气肿和小气道疾病在慢性阻塞性肺疾病中的作用和分布。
Ann Am Thorac Soc. 2019 Aug;16(8):990-997. doi: 10.1513/AnnalsATS.201810-669OC.
8
The boundaries of mild chronic obstructive pulmonary disease (COPD): design of the searching clinical COPD onset (SOON) study.轻度慢性阻塞性肺疾病(COPD)的界定:探索性临床COPD起病(SOON)研究的设计
BMJ Open. 2017 Aug 11;7(8):e015731. doi: 10.1136/bmjopen-2016-015731.
9
Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.保留比受损的肺活量测定法与小气道功能障碍和总肺容量降低有关。
Respir Res. 2022 Oct 31;23(1):298. doi: 10.1186/s12931-022-02216-1.
10
Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.基于人群研究的 CT 气道总计数与慢性阻塞性肺疾病进展风险。
Am J Respir Crit Care Med. 2018 Jan 1;197(1):56-65. doi: 10.1164/rccm.201704-0692OC.

引用本文的文献

1
Analysis of exhaled nitric oxide and its influencing factors in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼出一氧化氮及其影响因素分析
Front Med (Lausanne). 2025 Jul 7;12:1611947. doi: 10.3389/fmed.2025.1611947. eCollection 2025.
2
Incidence and Risk Factors of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease.结核病相关慢性阻塞性肺疾病的发病率及危险因素
Int J Chron Obstruct Pulmon Dis. 2025 Jun 26;20:2091-2102. doi: 10.2147/COPD.S523732. eCollection 2025.
3
Interrelationship Between Obstructive Sleep Apnea Syndrome and Small Airway Disease: A Comprehensive Review.

本文引用的文献

1
Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation.病毒诱导的气道免疫功能障碍在 COPD 发病机制、进展和恶化中的作用机制。
Front Immunol. 2020 Jun 16;11:1205. doi: 10.3389/fimmu.2020.01205. eCollection 2020.
2
Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lung.吸入香烟烟雾和炎性物质会导致肺部的表观遗传改变。
Sci Rep. 2020 Jul 9;10(1):11290. doi: 10.1038/s41598-020-67502-8.
3
Intermittent exposure to whole cigarette smoke alters the differentiation of primary small airway epithelial cells in the air-liquid interface culture.
阻塞性睡眠呼吸暂停综合征与小气道疾病的相互关系:综述
Biomedicines. 2025 Apr 8;13(4):905. doi: 10.3390/biomedicines13040905.
4
COPD Risk Phenotypes in Older Smokers: Evaluation in GLI- and GOLD-Defined Respiratory Impairment.老年吸烟者的慢性阻塞性肺疾病风险表型:在全球慢性阻塞性肺疾病倡议组织(GLI)和慢性阻塞性肺疾病全球倡议(GOLD)定义的呼吸功能损害中的评估
Lung. 2024 Nov 27;203(1):3. doi: 10.1007/s00408-024-00757-4.
5
Symptoms of COPD in the absence of airflow obstruction are more indicative of pre-COPD than overdiagnosis.慢性阻塞性肺疾病(COPD)在无气流受限情况下出现的症状,更提示慢性阻塞性肺疾病前期,而非过度诊断。
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00264-2024. eCollection 2024 Sep.
6
Uncovering the action mechanism of Shenqi Tiaoshen formula in the treatment of chronic obstructive pulmonary disease through network pharmacology, molecular docking, and experimental verification.通过网络药理学、分子对接和实验验证揭示参芪调神方治疗慢性阻塞性肺疾病的作用机制。
J Tradit Chin Med. 2024 Aug;44(4):770-783. doi: 10.19852/j.cnki.jtcm.20240610.002.
7
Capturing COPD heterogeneity: anomaly detection and parametric response mapping comparison for phenotyping on chest computed tomography.捕捉慢性阻塞性肺疾病的异质性:胸部计算机断层扫描表型分析的异常检测与参数反应映射比较
Front Med (Lausanne). 2024 Mar 1;11:1360706. doi: 10.3389/fmed.2024.1360706. eCollection 2024.
8
The Role of Osteopontin in Respiratory Health and Disease.骨桥蛋白在呼吸健康与疾病中的作用
J Pers Med. 2023 Aug 14;13(8):1259. doi: 10.3390/jpm13081259.
9
Clinical Use of an Exposure, Symptom, and Spirometry Algorithm to Stratify Smokers into COPD Risk Phenotypes: A Case Finding Study Combined with Smoking Cessation Counseling.使用暴露、症状和肺量计算法对吸烟者进行慢性阻塞性肺疾病(COPD)风险表型分层的临床应用:一项结合戒烟咨询的病例发现研究
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):248-258. doi: 10.15326/jcopdf.2022.0368.
10
CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity.CC16 作为诱导痰中的炎症生物标志物反映慢性阻塞性肺疾病(COPD)的严重程度。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 27;18:705-717. doi: 10.2147/COPD.S400999. eCollection 2023.
间歇性暴露于全烟香烟烟雾会改变气液界面培养中小气道上皮细胞的分化。
Sci Rep. 2020 Apr 10;10(1):6257. doi: 10.1038/s41598-020-63345-5.
4
Disease Progression Modeling in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的疾病进展建模。
Am J Respir Crit Care Med. 2020 Feb 1;201(3):294-302. doi: 10.1164/rccm.201908-1600OC.
5
Impulse oscillometry.脉冲振荡法
Adv Respir Med. 2019;87(4):235-238. doi: 10.5603/ARM.a2019.0039.
6
Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies.老年人正常肺功能下降率:前瞻性队列研究的系统评价。
BMJ Open. 2019 Jun 27;9(6):e028150. doi: 10.1136/bmjopen-2018-028150.
7
Diagnostic value of spirometry vs impulse oscillometry: A comparative study in children with sickle cell disease.肺量测定与脉冲震荡法诊断价值的比较:镰状细胞病患儿的一项对比研究。
Pediatr Pulmonol. 2019 Sep;54(9):1422-1430. doi: 10.1002/ppul.24382. Epub 2019 Jun 18.
8
Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review.晚期糖基化终产物受体与环境暴露相关的阻塞性气道疾病:系统评价。
Eur Respir Rev. 2019 Mar 27;28(151). doi: 10.1183/16000617.0096-2018. Print 2019 Mar 31.
9
The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.峰值指数:气流阻塞严重度和异质性的肺量计指标。
Ann Am Thorac Soc. 2019 Aug;16(8):982-989. doi: 10.1513/AnnalsATS.201811-812OC.
10
Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.血清丝氨酸蛋白酶抑制剂 3G、基质金属蛋白酶-9 与组织金属蛋白酶抑制剂-1、-2 与慢性阻塞性肺疾病严重程度的关系。
Biomolecules. 2019 Feb 13;9(2):62. doi: 10.3390/biom9020062.